Ceftazidime/Avibactam and Ceftolozane/Tazobactam for Multidrug-Resistant Gram Negatives in Patients with Hematological Malignancies: Current Experiences

Patients suffering from hematological malignancies are at high risk for severe infections, including in particular bloodstream infections, which represent one of the most frequent life-threatening complications for these patients, with reported mortality rates reaching 40%. Furthermore, a worrisome...

Descripción completa

Detalles Bibliográficos
Autores principales: Criscuolo, Marianna, Trecarichi, Enrico Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168285/
https://www.ncbi.nlm.nih.gov/pubmed/32028615
http://dx.doi.org/10.3390/antibiotics9020058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168285/
https://www.ncbi.nlm.nih.gov/pubmed/32028615
http://dx.doi.org/10.3390/antibiotics9020058

Ejemplares similares